Company intelligence / Profile preview

Feromics

Toronto, Ontario, Canadaferomics.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Feromics Inc. develops precision immunotherapies using its proprietary Intelligent Design™ platform and functional immunomics workflow. The company leverages deep-learning algorithms and advanced bioinformatics to analyze multi-modal immune data at the DNA, RNA, and protein levels. Its primary mission centers on transforming cancer care through personalized medicine approaches that optimize donor selection for allogeneic therapies and match patients with the most effective immunotherapy based on their unique profiles. There are also indications of a novel focus on iron biology as it relates to human health innovation.

Therapeutic areas
OncologyImmunologyHematology
Modalities
Immunotherapies (including allogeneic and personalized approaches)AI-driven bioinformatics for immune profilingGenomics-based researchIron biology focus (possible additional modality)
Industry
Biotech
02

Drug pipeline

2 assets

F01-50

Preclinical

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Feromics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Feromics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call